stockrowAbbott Laboratories
ABT Healthcare Medical Devices
Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- −43.6%
- Free cash flow
- +28.9%
- Total debt
- +142.7%
Quarter to September 2026, against a year earlier
Follow ABT
Alert me
Abbott Laboratories (ABT) Operating margin
Abbott Laboratories's operating margin over the twelve months to 30 September 2026 was 13.8%, down 4.4 percentage points from fiscal 2025 (18.2%). Over the past ten years it has ranged from 5.71% (fiscal 2017) to 19.6% (fiscal 2021); the current reading is higher than 82% of that period. That is above the Medical Devices industry median of −15.1% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 18.2% | 1.90 |
| FY2024 | 16.3% | 0.12 |
| FY2023 | 16.2% | (3.01) |
| FY2022 | 19.2% | (0.40) |
| FY2021 | 19.6% | 4.08 |
| FY2020 | 15.5% | 1.27 |
| FY2019 | 14.2% | 2.27 |
| FY2018 | 11.9% | 6.23 |
| FY2017 | 5.71% | (8.80) |
| FY2016 | 14.5% | 0.46 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 10.4% | (3.00) |
| Jun 2026 | 13.4% | 1.39 |
| Mar 2026 | 12.1% | (7.59) |
| Dec 2025 | 19.6% | 1.55 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| DXCM DexCom, Inc. compare | 24.0% |
| EW Edwards Lifesciences Corporation compare | 21.6% |
| SYK Stryker Corporation compare | 20.7% |
| STE STERIS plc compare | 19.0% |
| BSX Boston Scientific Corporation compare | 18.7% |
| MDT Medtronic PLC compare | 18.1% |
| ABT Abbott Laboratories | 13.8% |
| GEHC GE HealthCare Technologies Inc. compare | 13.3% |
| PHG Koninklijke Philips N.V. compare | 8.68% |
| Medical Devices industry median | −15.1% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ABT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement